United States · FDA National Drug Code directory
mirtazapine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-408_4e8e5591-9b05-8885-e063-6394a90a02e8
- Product NDC
- 31722-408
- Form
- TABLET, FILM COATED
- Composition / generic term
- mirtazapine
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251002
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRTAZAPINE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (31722-408-05) · 31722-408-05
- 1000 TABLET, FILM COATED in 1 BOTTLE (31722-408-10) · 31722-408-10
- 30 TABLET, FILM COATED in 1 BOTTLE (31722-408-30) · 31722-408-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →